non-parametric friedman’s anova test origin 8.5.1 (OriginLab corp)
OriginLab corp manufactures this product 
90
Structured Review
OriginLab corp
non-parametric friedman’s anova test origin 8.5.1
Non Parametric Friedman’s Anova Test Origin 8.5.1, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-parametric+friedman%E2%80%99s+anova+test+origin+8%2E5%2E1/non+parametric+friedman%E2%80%99s+anova+test+origin+8+5+1/pm31066020-119-15-17
Average 90 stars, based on 1 article reviews
Non Parametric Friedman’s Anova Test Origin 8.5.1, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-parametric+friedman%E2%80%99s+anova+test+origin+8%2E5%2E1/non+parametric+friedman%E2%80%99s+anova+test+origin+8+5+1/pm31066020-119-15-17
Average 90 stars, based on 1 article reviews
non-parametric friedman’s anova test origin 8.5.1 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Selenium Overcomes Doxorubicin Resistance in Their Nano-platforms Against Breast and Colon Cancers. Article Snippet: Colon cancer in men and breast cancer in women are regarded as major health burdens, accounting for majority of cancer diagnoses globally.. Doxorubicin (DOX) resistance in breast and colon cancers represents the main reason of unsuccessful therapy.. The rationale of this study is to explore whether selenium nanoparticles (nano-Se) can overcome this resistance obstacle of DOX nanoparticles (nano-DOX) in these cancerous cells. |